Given what came out in the Conference, the award recognition of the quality and integrity of the technology and the fact that the N-Assay is a technology clearly better by a considerable margin than anything in current use including the PCR then I consider that there is a very good chance that a significant medical equipment company will approach NanoLogix to partner or acquire. If not, then there is likely a quite significant probability that NanoLogix will expand or outsource its production and profit in that way. This is clearly a pivotal moment in the company's development and I am willing to ride with it for a bit to experience the rapidly increasing positives.